LiverSource »  Faculty »  Interventional Radiology »  Robert K. Kerlan, Jr. M.D.
 
Related Programs
Department of Surgery Websites

Make a Gift

A gift to the UCSF Department of Surgery can help physicians and scientist find treatments and cures for serious liver diseases such as hepatitis B & C, and liver cancer.

How you can help »
LiverSource »  Faculty »  Interventional Radiology »  Robert K. Kerlan, Jr. M.D.

Robert K. Kerlan, Jr. M.D.

Robert K. Kerlan Jr., M.D.
Professor of Clinical Radiology,
Department of Radiology
Chief of Interventional Radiology,
UCSF Medical Center

Contact Information

Interventional Radiology
505 Parnassus Ave., Room M-361
San Francisco, CA 94143
Phone: (415) 353-1300
Appointments: (415) 353-2573
Fax: (415) 353-8570
bob.kerlan@radiology.ucsf.edu

Education

  • University of Southern California School of Medicine 1977

Residencies

  • UCSF Medical Center, Diagnostic Radiology 1981

Fellowships

Postdoctoral Training

Board Certification

  • American Board of Radiology, Diagnostic Radiology - General
  • American Board of Radiology, Vascular & Interventional Radiology - Subspecialty

Program Affiliations

  • Department of Radiology, UCSF
  • UCSF Helen Diller Family Comprehensive Cancer Center

Clinical Expertise

  • Chemoembolization
  • Hepatocellular Carcinoma (Primary Liver Cancer)
  • Interventional Radiology
  • Liver Transplantation

Research Interests

  • Chemoembolization (TACE) in Cirrhosis and Hepatocellular Carcinoma
  • Liver Transplantation

Website Links

  • Profile at UCSF Clinical & Translational Science Institute

Selected Publications

  1. Thomas MB, Jaffe D, Choti MM, Belghiti J, Curley S, Fong Y, Gores G, Kerlan R, Merle P, O'Neil B, Poon R, Schwartz L, Tepper J, Yao F, Haller D, Mooney M, Venook A. Hepatocellular carcinoma: consensus recommendations of the national cancer institute clinical trials planning meeting. J Clin Oncol. 2010 Sep 1; 28(25):3994-4005.
  2. Roberts JP, Venook A, Kerlan R, Yao F. Hepatocellular carcinoma: Ablate and wait versus rapid transplantation. Liver Transpl. 2010 Aug; 16(8):925-9.
  3. Posselt AM, Bellin MD, Tavakol M, Szot GL, Frassetto LA, Masharani U, Kerlan RK, Fong L, Vincenti FG, Hering BJ, Bluestone JA, Stock PG. Islet Transplantation in Type 1 Diabetics Using an Immunosuppressive Protocol Based on the Anti-LFA-1 Antibody Efalizumab. Am J Transplant. 2010 Aug; 10(8):1870-80.
  4. Kwan SW, Bhargavan M, Kerlan RK, Sunshine JH. Effect of advanced imaging technology on how biopsies are done and who does them. Radiology. 2010 Sep; 256(3):751-8.
  5. Kwan SW, Kerlan RK, Sunshine JH. Utilization of interventional oncology treatments in the United States. J Vasc Interv Radiol. 2010 Jul; 21(7):1054-60.
View All Publications at UCSF Profiles (Powered by CTSI)
X